Corrections & Amplifications This headline was corrected at 0731 GMT to reflect GSK PLC 4Q Pre-Items, Pre-Tax Pft GBP1.56B, not GBP8.11B Corrections & Amplifications This headline was corrected…
Read more GSK PLC 4Q Pre-items, Pretax Pft GBP1.56BGSK GSK, +5.45% shares surged 6% in London action as the U.K. pharmaceutical said it reached a settlement over its Zantac heartburn medication litigation with a plaintiff in…
Read more GSK shares surge after reaching settlement on Zantac ahead of California trialA flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday, with Moderna telling investors it expects to generate some $5 billion in sales…
Read more Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic responseChina counted more than 10,000 fresh COVID cases on Friday sparking further restrictions on movement, but also eased some travel requirements in a move welcomed by financial markets.…
Read more China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a dayBy Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients with relapsed or refractory multiple myeloma didn’t meet its primary endpoint of progression-free…
Read more GSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary Endpoint
